Johnson & Johnson has unveiled groundbreaking findings on nipocalimab, an investigational FcRn blocker, in a recent ...

We constructed miniaturized autoantigen arrays to perform large-scale multiplex characterization of autoantibody responses directed against structurally diverse autoantigens, using submicroliter ...

LONDON - Oncimmune Holdings PLC (AIM: ONC.L), a company specializing in autoantibody profiling for the pharmaceutical and biotechnology sectors, has announced the scheduling of a General Meeting (GM) ...